首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms
【24h】

Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms

机译:类风湿关节炎的疾病缓解型抗风湿药物的持续缓解:随着疾病症状的消退,可实现的结果越来越多

获取原文
获取原文并翻译 | 示例
       

摘要

Objective Disease-modifying antirheumatic drug (DMARD)-free sustained remission, the sustained absence of synovitis after cessation of DMARD therapy, is a relevant long-term outcome of rheumatoid arthritis (RA) if (1) its occurrence is promoted by treatment and (2) this status reflects resolution of symptoms and disability. This study investigated both items.
机译:目的如果(1)通过治疗促进类风湿关节炎(RA)的发生并且((1)通过治疗促进类风湿关节炎(RA)的发生,则无相关疾病改良抗风湿药(DMARD)的持续缓解,停止DMARD治疗后滑膜炎的持续缺乏是长期的相关结果。 2)此状态反映症状和残疾的缓解。这项研究调查了这两个项目。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号